Jubilant Pharmova Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1061.60

-30.25 (-2.77%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1061.60

-30.25 (-2.77%)
16:02 Dec 20

Quality

68/100
High Financial Strength

Valuation

61/100
Affordable Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	6098.54	6130.16	6281.73	6702.9	6919.7
Operating Expenses +	4702.07	4973.83	5505.48	5802.1	5889.4
Raw Material	1516.38	1550.32	1918.63	2062.5	2119.9
Increase Decrease in Cost	19.63	-62.32	-40.7	78.2	59.9
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1922.88	2043.39	2166.02	2216	2253.7
Miscellaneous Expenses	1578.44	1845.68	1965.97	1927.8	1455.9
Operating Profit	1396.47	1156.33	776.25	900.8	1030.3
Other Income	17.64	11.29	38.33	68.7	85.9
Depreciation	348.95	381.7	554.03	381.9	377.7
Interest	184.1	145.49	188.2	272.3	276.3
Profit before tax and exceptio..	881.06	640.43	72.34	315.3	462.2
Exceptional Items	-21.23	0	-56.82	-168.9	212.8
PBT	859.82	640.43	15.53	146.4	249.4
Provision for Taxation	297.22	217.43	92.66	97.8	102.5
Net Profit	824.36	423	-77.13	48.6	572.5
NET Profit after MI	835.87	413.94	-60.98	77.1	593.1
EPS	52.48	26	-3.83	4.86	37.44
Operating Profit Margin (%)	22.9	18.86	12.36	13.44	14.89
Net Profit Margin (%)	13.71	6.75	-0.97	1.15	8.57

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	50.70	50.70	50.70	50.70	50.70
FII	17.90	19.50	19.10	20.30	23.20
MF	3.10	2.20	2.30	1.50	0.40
Public	25.20	25.20	25.90	25.60	23.90
Others	0.50	0.50	0.60	0.50	0.60
Others	2.60	1.90	1.40	1.40	1.20